Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$3.04M Buy
14,320
+868
+6% +$200K 0.07% 113
2021
Q2
$3.28M Buy
13,452
+171
+1% +$42.1K 0.08% 105
2021
Q1
$3.3M Buy
13,281
+5,569
+72% +$1.33M 0.09% 92
2020
Q4
$1.77M Buy
7,712
+1,302
+20% +$300K 0.05% 137
2020
Q3
$1.63M Buy
6,410
+1,771
+38% +$439K 0.06% 110
2020
Q2
$1.09M Buy
4,639
+2,713
+141% +$619K 0.04% 130
2020
Q1
$390K Sell
1,926
-475
-20% -$104K 0.02% 214
2019
Q4
$579K Buy
2,401
+128
+6% +$28.2K 0.03% 215
2019
Q3
$440K Buy
2,273
+543
+31% +$104K 0.02% 231
2019
Q2
$319K Buy
1,730
+301
+21% +$53.9K 0.02% 275
2019
Q1
$271K Buy
+1,429
New +$273K 0.01% 274
2018
Q4
Sell
-1,746
Closed -$362K 298
2018
Q3
$362K Buy
1,746
+256
+17% +$50.5K 0.02% 247
2018
Q2
$275K Buy
1,490
+158
+12% +$27.9K 0.02% 266
2018
Q1
$227K Buy
1,332
+45
+3% +$8.26K 0.02% 303
2017
Q4
$224K Sell
1,287
-23
-2% -$4.07K 0.02% 305
2017
Q3
$244K Sell
1,310
-132
-9% -$23.4K 0.02% 284
2017
Q2
$248K Buy
1,442
+30
+2% +$4.88K 0.02% 248
2017
Q1
$232K Sell
1,412
-27
-2% -$4.49K 0.02% 265
2016
Q4
$210K Sell
1,439
-668
-32% -$101K 0.02% 258
2016
Q3
$352K Buy
+2,107
New +$356K 0.03% 186

Other funds holding AMGN

Homrich & Berg's AMGN Position: Q3 2021 in Review

Homrich & Berg increased its Amgen (AMGN) stake by 6.5% in Q3 2021, buying an estimated $200K and bringing the position to 14,320 shares worth $3.04M. The position accounts for 0.07% of the portfolio, ranked #113.

Homrich & Berg first reported a position in AMGN in Q3 2016 and has held it in 20 quarters since. The position peaked at $3.3M in Q1 2021. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

  • Homrich & Berg held 14,320 shares of Amgen worth $3.04M as of Q3 2021.
  • Homrich & Berg bought 868 Amgen shares in Q3 2021, an estimated $200K.
  • Amgen made up 0.07% of Homrich & Berg's portfolio in Q3 2021, its #113 holding.
  • Homrich & Berg first reported a position in Amgen in Q3 2016 and has held it in 20 quarters since.
  • Homrich & Berg's Amgen position peaked at $3.3M in Q1 2021.
  • 2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on Homrich & Berg's 13F filing for Q3 2021, filed 8 Dec 2021.